{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:44:30Z","timestamp":1793119470416,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00134-024-07586-2","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T14:02:59Z","timestamp":1725285779000},"page":"1580-1592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-0829","authenticated-orcid":false,"given":"Massimo","family":"Girardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole P.","family":"Juffermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Povoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Coloretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Parchim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"7586_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS et al (2016) Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:775\u2013787. https:\/\/doi.org\/10.1001\/jama.2016.0289","journal-title":"JAMA"},{"key":"7586_CR2","doi-asserted-by":"publisher","unstructured":"Shankar-Hari M, Calandra T, Soares MP, Bauer M, Wiersinga WJ, Prescott HC, et al. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies. The Lancet Respiratory Medicine 2024;0. https:\/\/doi.org\/10.1016\/S2213-2600(23)00468-X.","DOI":"10.1016\/S2213-2600(23)00468-X"},{"key":"7586_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann B, Massberg S (2013) Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13:34\u201345. https:\/\/doi.org\/10.1038\/nri3345","journal-title":"Nat Rev Immunol"},{"key":"7586_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jtha.2023.07.020","volume":"22","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Levi M, Levy JH (2024) Thromboinflammation in acute injury: infections, heatstroke, and trauma. J Thromb Haemost 22:7\u201322. https:\/\/doi.org\/10.1016\/j.jtha.2023.07.020","journal-title":"J Thromb Haemost"},{"key":"7586_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","volume":"49","author":"J Helms","year":"2023","unstructured":"Helms J, Iba T, Connors JM, Gando S, Levi M, Meziani F et al (2023) How to manage coagulopathies in critically ill patients. Intensive Care Med 49:273\u2013290. https:\/\/doi.org\/10.1007\/s00134-023-06980-6","journal-title":"Intensive Care Med"},{"key":"7586_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532\u20131535. https:\/\/doi.org\/10.1126\/science.1092385","journal-title":"Science"},{"key":"7586_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/cc9231","volume":"14","author":"F Meziani","year":"2010","unstructured":"Meziani F, Delabranche X, Asfar P, Toti F (2010) Bench-to-bedside review: circulating microparticles\u2014a new player in sepsis? Crit Care 14:236. https:\/\/doi.org\/10.1186\/cc9231","journal-title":"Crit Care"},{"key":"7586_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/SHK.0000000000000509","volume":"45","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Meng H, Ma R, He Z, Wu X, Cao M et al (2016) Circulating microparticles, blood cells, and endothelium induce procoagulant activity in sepsis through phosphatidylserine exposure. Shock 45:299\u2013307. https:\/\/doi.org\/10.1097\/SHK.0000000000000509","journal-title":"Shock"},{"key":"7586_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/SHK.0000000000000980","volume":"49","author":"L Stiel","year":"2018","unstructured":"Stiel L, Meziani F, Helms J (2018) Neutrophil Activation During Septic Shock. Shock 49:371\u2013384. https:\/\/doi.org\/10.1097\/SHK.0000000000000980","journal-title":"Shock"},{"key":"7586_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101239","volume":"26","author":"N Robinson","year":"2019","unstructured":"Robinson N, Ganesan R, Heged\u0171s C, Kov\u00e1cs K, Kufer TA, Vir\u00e1g L (2019) Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos. Redox Biol 26:101239. https:\/\/doi.org\/10.1016\/j.redox.2019.101239","journal-title":"Redox Biol"},{"key":"7586_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.immuni.2011.09.020","volume":"35","author":"L Duprez","year":"2011","unstructured":"Duprez L, Takahashi N, Van Hauwermeiren F, Vandendriessche B, Goossens V, Vanden Berghe T et al (2011) RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35:908\u2013918. https:\/\/doi.org\/10.1016\/j.immuni.2011.09.020","journal-title":"Immunity"},{"key":"7586_CR12","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1182\/blood-2002-06-1887","volume":"101","author":"WC Aird","year":"2003","unstructured":"Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765\u20133777. https:\/\/doi.org\/10.1182\/blood-2002-06-1887","journal-title":"Blood"},{"key":"7586_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2021.100095","volume":"12","author":"T Pape","year":"2021","unstructured":"Pape T, Hunkem\u00f6ller AM, K\u00fcmpers P, Haller H, David S, Stahl K (2021) Targeting the \u201csweet spot\u201d in septic shock - A perspective on the endothelial glycocalyx regulating proteins Heparanase-1 and -2. Matrix Biol Plus 12:100095. https:\/\/doi.org\/10.1016\/j.mbplus.2021.100095","journal-title":"Matrix Biol Plus"},{"key":"7586_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/jth.14371","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH (2019) Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost 17:283\u2013294. https:\/\/doi.org\/10.1111\/jth.14371","journal-title":"J Thromb Haemost"},{"key":"7586_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","volume":"7","author":"X Delabranche","year":"2017","unstructured":"Delabranche X, Helms J, Meziani F (2017) Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care 7:117. https:\/\/doi.org\/10.1186\/s13613-017-0339-5","journal-title":"Ann Intensive Care"},{"key":"7586_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-020-2799-5","volume":"24","author":"K Stahl","year":"2020","unstructured":"Stahl K, Schmidt JJ, Seeliger B, Schmidt BMW, Welte T, Haller H et al (2020) Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit Care 24:71. https:\/\/doi.org\/10.1186\/s13054-020-2799-5","journal-title":"Crit Care"},{"key":"7586_CR17","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","volume":"122","author":"BG Yipp","year":"2013","unstructured":"Yipp BG, Kubes P (2013) NETosis: how vital is it? Blood 122:2784\u20132794. https:\/\/doi.org\/10.1182\/blood-2013-04-457671","journal-title":"Blood"},{"key":"7586_CR18","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/aas.13797","volume":"65","author":"RG Hahn","year":"2021","unstructured":"Hahn RG, Patel V, Dull RO (2021) Human glycocalyx shedding: Systematic review and critical appraisal. Acta Anaesthesiol Scand 65:590\u2013606. https:\/\/doi.org\/10.1111\/aas.13797","journal-title":"Acta Anaesthesiol Scand"},{"key":"7586_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08830185.2018.1533009","volume":"38","author":"H Minasyan","year":"2019","unstructured":"Minasyan H, Flachsbart F (2019) Blood coagulation: a powerful bactericidal mechanism of human innate immunity. Int Rev Immunol 38:3\u201317. https:\/\/doi.org\/10.1080\/08830185.2018.1533009","journal-title":"Int Rev Immunol"},{"key":"7586_CR20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1126\/science.1101245","volume":"305","author":"H Sun","year":"2004","unstructured":"Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY et al (2004) Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305:1283\u20131286. https:\/\/doi.org\/10.1126\/science.1101245","journal-title":"Science"},{"key":"7586_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1160\/TH14-01-0053","volume":"112","author":"T van der Poll","year":"2014","unstructured":"van der Poll T, Herwald H (2014) The coagulation system and its function in early immune defense. Thromb Haemost 112:640\u2013648. https:\/\/doi.org\/10.1160\/TH14-01-0053","journal-title":"Thromb Haemost"},{"key":"7586_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0009-3084(94)90157-0","volume":"67\u201368","author":"E Angl\u00e9s-Cano","year":"1994","unstructured":"Angl\u00e9s-Cano E (1994) Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces. Chem Phys Lipids 67\u201368:353\u2013362. https:\/\/doi.org\/10.1016\/0009-3084(94)90157-0","journal-title":"Chem Phys Lipids"},{"key":"7586_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1538-7836.2010.03787.x","volume":"8","author":"J Morser","year":"2010","unstructured":"Morser J, Gabazza EC, Myles T, Leung LLK (2010) What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? J Thromb Haemost 8:868\u2013876. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03787.x","journal-title":"J Thromb Haemost"},{"key":"7586_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","volume":"118","author":"S Zeerleder","year":"2006","unstructured":"Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA (2006) TAFI and PAI-1 levels in human sepsis. Thromb Res 118:205\u2013212. https:\/\/doi.org\/10.1016\/j.thromres.2005.06.007","journal-title":"Thromb Res"},{"key":"7586_CR25","doi-asserted-by":"publisher","first-page":"14270","DOI":"10.1096\/fj.201901363RRR","volume":"33","author":"DB da Cruz","year":"2019","unstructured":"da Cruz DB, Helms J, Aquino LR, Stiel L, Cougourdan L, Broussard C et al (2019) DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma. FASEB J 33:14270\u201314280. https:\/\/doi.org\/10.1096\/fj.201901363RRR","journal-title":"FASEB J"},{"key":"7586_CR26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/jth.15697","volume":"20","author":"AE Mast","year":"2022","unstructured":"Mast AE, Ruf W (2022) Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy. J Thromb Haemost 20:1290\u20131300. https:\/\/doi.org\/10.1111\/jth.15697","journal-title":"J Thromb Haemost"},{"key":"7586_CR27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/adc.2010.199919","volume":"96","author":"E Chalmers","year":"2011","unstructured":"Chalmers E, Cooper P, Forman K, Grimley C, Khair K, Minford A et al (2011) Purpura fulminans: recognition, diagnosis and management. Arch Dis Child 96:1066\u20131071. https:\/\/doi.org\/10.1136\/adc.2010.199919","journal-title":"Arch Dis Child"},{"key":"7586_CR28","doi-asserted-by":"publisher","unstructured":"Ed Rainger G, Chimen M, Harrison MJ, Yates CM, Harrison P, Watson SP, et al. The role of platelets in the recruitment of leukocytes during vascular disease. Platelets 2015;26:507\u201320. https:\/\/doi.org\/10.3109\/09537104.2015.1064881.","DOI":"10.3109\/09537104.2015.1064881"},{"key":"7586_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1172\/JCI116623","volume":"92","author":"DE Lorant","year":"1993","unstructured":"Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM et al (1993) Inflammatory roles of P-selectin. J Clin Invest 92:559\u2013570. https:\/\/doi.org\/10.1172\/JCI116623","journal-title":"J Clin Invest"},{"key":"7586_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-0-387-78952-1_7","volume":"632","author":"EIB Peerschke","year":"2008","unstructured":"Peerschke EIB, Yin W, Ghebrehiwet B (2008) Platelet mediated complement activation. Adv Exp Med Biol 632:81\u201391. https:\/\/doi.org\/10.1007\/978-0-387-78952-1_7","journal-title":"Adv Exp Med Biol"},{"key":"7586_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement System Part I - Molecular Mechanisms of Activation and Regulation. Front Immunol 6:262. https:\/\/doi.org\/10.3389\/fimmu.2015.00262","journal-title":"Front Immunol"},{"key":"7586_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.thromres.2004.06.028","volume":"114","author":"CT Esmon","year":"2004","unstructured":"Esmon CT (2004) The impact of the inflammatory response on coagulation. Thromb Res 114:321\u2013327. https:\/\/doi.org\/10.1016\/j.thromres.2004.06.028","journal-title":"Thromb Res"},{"key":"7586_CR33","doi-asserted-by":"crossref","unstructured":"Taylor FB, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327\u201330.","DOI":"10.1055\/s-0037-1616068"},{"key":"7586_CR34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.ccm.0000202209.42491.38","volume":"34","author":"S Gando","year":"2006","unstructured":"Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K et al (2006) A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 34:625\u2013631. https:\/\/doi.org\/10.1097\/01.ccm.0000202209.42491.38","journal-title":"Crit Care Med"},{"key":"7586_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/jth.14482","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, Levi M et al (2019) Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J Thromb Haemost 17:1265\u20131268. https:\/\/doi.org\/10.1111\/jth.14482","journal-title":"J Thromb Haemost"},{"key":"7586_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13613-022-01093-7","volume":"13","author":"T Schmoch","year":"2023","unstructured":"Schmoch T, M\u00f6hnle P, Weigand MA, Briegel J, Bauer M, Bloos F et al (2023) The prevalence of sepsis-induced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials. Ann Intensive Care 13:3. https:\/\/doi.org\/10.1186\/s13613-022-01093-7","journal-title":"Ann Intensive Care"},{"key":"7586_CR37","doi-asserted-by":"publisher","first-page":"107602962312076","DOI":"10.1177\/10760296231207630","volume":"29","author":"Y Chen","year":"2023","unstructured":"Chen Y, Chen W, Ba F, Zheng Y, Zhou Y, Shi W et al (2023) Prognostic Accuracy of the Different Scoring Systems for Assessing Coagulopathy in Sepsis: A Retrospective Study. Clin Appl Thromb Hemost 29:10760296231207630. https:\/\/doi.org\/10.1177\/10760296231207630","journal-title":"Clin Appl Thromb Hemost"},{"key":"7586_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12879-024-09154-x","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Liu H, Wang N, Wang F, Shang N, Guo S et al (2024) Persistent high sepsis-induced coagulopathy and sequential organ failure assessment scores can predict the 28-day mortality of patients with sepsis: A prospective study. BMC Infect Dis 24:282. https:\/\/doi.org\/10.1186\/s12879-024-09154-x","journal-title":"BMC Infect Dis"},{"key":"7586_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00134-009-1723-x","volume":"36","author":"N Lerolle","year":"2010","unstructured":"Lerolle N, Nochy D, Gu\u00e9rot E, Bruneval P, Fagon J-Y, Diehl J-L et al (2010) Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 36:471\u2013478. https:\/\/doi.org\/10.1007\/s00134-009-1723-x","journal-title":"Intensive Care Med"},{"key":"7586_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.thromres.2017.05.031","volume":"156","author":"VM Tani","year":"2017","unstructured":"Tani VM, Assis-Mendon\u00e7a GR, da Silva TB, Rogerio F, De Paula EV (2017) Microvascular thrombosis in sepsis: An autopsy study. Thromb Res 156:23\u201325. https:\/\/doi.org\/10.1016\/j.thromres.2017.05.031","journal-title":"Thromb Res"},{"key":"7586_CR41","doi-asserted-by":"publisher","unstructured":"White KC, Serpa-Neto A, Hurford R, Clement P, Laupland KB, See E, et al. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med 2023;49:1079\u201389. https:\/\/doi.org\/10.1007\/s00134-023-07138-0.","DOI":"10.1007\/s00134-023-07138-0"},{"key":"7586_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13613-023-01216-8","volume":"13","author":"J Helms","year":"2023","unstructured":"Helms J, Merdji H, Loewert S, Severac F, Monnier A, Kaurin J et al (2023) Disseminated intravascular coagulation is strongly associated with severe acute kidney injury in patients with septic shock. Ann Intensive Care 13:119. https:\/\/doi.org\/10.1186\/s13613-023-01216-8","journal-title":"Ann Intensive Care"},{"key":"7586_CR43","doi-asserted-by":"publisher","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA 2019;321:2003\u201317. https:\/\/doi.org\/10.1001\/jama.2019.5791.","DOI":"10.1001\/jama.2019.5791"},{"key":"7586_CR44","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/cc6823","volume":"12","author":"C Langenberg","year":"2008","unstructured":"Langenberg C, Bagshaw SM, May CN, Bellomo R (2008) The histopathology of septic acute kidney injury: a systematic review. Crit Care 12:R38. https:\/\/doi.org\/10.1186\/cc6823","journal-title":"Crit Care"},{"key":"7586_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","volume":"84","author":"LK Torres","year":"2022","unstructured":"Torres LK, Pickkers P, van der Poll T (2022) Sepsis-Induced Immunosuppression. Annu Rev Physiol 84:157\u2013181. https:\/\/doi.org\/10.1146\/annurev-physiol-061121-040214","journal-title":"Annu Rev Physiol"},{"key":"7586_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","volume":"12","author":"S Cajander","year":"2024","unstructured":"Cajander S, Kox M, Scicluna BP, Weigand MA, Mora RA, Floh\u00e9 SB et al (2024) Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine. Lancet Respir Med 12:305\u2013322. https:\/\/doi.org\/10.1016\/S2213-2600(23)00330-2","journal-title":"Lancet Respir Med"},{"key":"7586_CR47","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/cc5783","volume":"11","author":"FA Bozza","year":"2007","unstructured":"Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN et al (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11:R49. https:\/\/doi.org\/10.1186\/cc5783","journal-title":"Crit Care"},{"key":"7586_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1164\/rccm.201302-0355OC","volume":"188","author":"JA Russell","year":"2013","unstructured":"Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, Thair S et al (2013) Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med 188:356\u2013364. https:\/\/doi.org\/10.1164\/rccm.201302-0355OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7586_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14:121\u2013137. https:\/\/doi.org\/10.1038\/nrneph.2017.165","journal-title":"Nat Rev Nephrol"},{"key":"7586_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","volume":"17","author":"D Grimaldi","year":"2017","unstructured":"Grimaldi D, Pradier O, Hotchkiss RS, Vincent J-L (2017) Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis. Lancet Infect Dis 17:18. https:\/\/doi.org\/10.1016\/S1473-3099(16)30541-2","journal-title":"Lancet Infect Dis"},{"key":"7586_CR51","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3390\/biomedicines10123150","volume":"10","author":"R Cusack","year":"2022","unstructured":"Cusack R, Leone M, Rodriguez AH, Martin-Loeches I (2022) Endothelial Damage and the Microcirculation in Critical Illness. Biomedicines 10:3150. https:\/\/doi.org\/10.3390\/biomedicines10123150","journal-title":"Biomedicines"},{"key":"7586_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1210\/edrv.21.2.0396","volume":"21","author":"JP Hinson","year":"2000","unstructured":"Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138\u2013167. https:\/\/doi.org\/10.1210\/edrv.21.2.0396","journal-title":"Endocr Rev"},{"key":"7586_CR53","doi-asserted-by":"publisher","unstructured":"Valenzuela-S\u00e1nchez F, Valenzuela-M\u00e9ndez B, Rodr\u00edguez-Guti\u00e9rrez JF, Estella-Garc\u00eda \u00c1, Gonz\u00e1lez-Garc\u00eda M\u00c1. New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure. Ann Transl Med 2016;4:329. https:\/\/doi.org\/10.21037\/atm.2016.08.65.","DOI":"10.21037\/atm.2016.08.65"},{"key":"7586_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.thromres.2018.09.059","volume":"171","author":"Y Fang","year":"2018","unstructured":"Fang Y, Li C, Shao R, Yu H, Zhang Q (2018) The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: A prospective observational study. Thromb Res 171:149\u2013154. https:\/\/doi.org\/10.1016\/j.thromres.2018.09.059","journal-title":"Thromb Res"},{"key":"7586_CR55","doi-asserted-by":"publisher","first-page":"107602962412380","DOI":"10.1177\/10760296241238010","volume":"30","author":"Y Chi","year":"2024","unstructured":"Chi Y, Yu S, Yin J, Liu D, Zhuo M, Li X (2024) Role of Angiopoietin\/Tie2 System in Sepsis: A Potential Therapeutic Target. Clin Appl Thromb Hemost 30:10760296241238010. https:\/\/doi.org\/10.1177\/10760296241238010","journal-title":"Clin Appl Thromb Hemost"},{"key":"7586_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J (2017) New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 7:e017046. https:\/\/doi.org\/10.1136\/bmjopen-2017-017046","journal-title":"BMJ Open"},{"key":"7586_CR57","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jtha.2022.11.032","volume":"21","author":"T Iba","year":"2023","unstructured":"Iba T, Levy JH, Thachil J, Susen S, Levi M, Scarlatescu E (2023) Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation. J Thromb Haemost 21:691\u2013699. https:\/\/doi.org\/10.1016\/j.jtha.2022.11.032","journal-title":"J Thromb Haemost"},{"key":"7586_CR58","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY et al (2019) Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients with Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA - Journal of the American Medical Association 321:1993\u20132002. https:\/\/doi.org\/10.1001\/jama.2019.5358","journal-title":"JAMA - Journal of the American Medical Association"},{"key":"7586_CR59","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","volume":"48","author":"M Levi","year":"2020","unstructured":"Levi M, Vincent J-L, Tanaka K, Radford AH, Kayanoki T, Fineberg DA et al (2020) Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy. Crit Care Med 48:1140\u20131147. https:\/\/doi.org\/10.1097\/CCM.0000000000004426","journal-title":"Crit Care Med"},{"key":"7586_CR60","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1182\/blood-2016-09-693655","volume":"128","author":"A Greinacher","year":"2016","unstructured":"Greinacher A, Selleng S (2016) How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood 128:3032\u20133042. https:\/\/doi.org\/10.1182\/blood-2016-09-693655","journal-title":"Blood"},{"key":"7586_CR61","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/aas.13036","volume":"62","author":"L Russell","year":"2018","unstructured":"Russell L, Madsen MB, Dahl M, Kampmann P, Perner A (2018) Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients. Acta Anaesthesiol Scand 62:196\u2013206. https:\/\/doi.org\/10.1111\/aas.13036","journal-title":"Acta Anaesthesiol Scand"},{"key":"7586_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcrc.2017.09.183","volume":"44","author":"GR Davies","year":"2018","unstructured":"Davies GR, Lawrence M, Pillai S, Mills GM, Aubrey R, Thomas D et al (2018) The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: A prospective observational study. J Crit Care 44:7\u201311. https:\/\/doi.org\/10.1016\/j.jcrc.2017.09.183","journal-title":"J Crit Care"},{"key":"7586_CR63","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/cc13721","volume":"18","author":"MC M\u00fcller","year":"2014","unstructured":"M\u00fcller MC, Meijers JC, Vroom MB, Juffermans NP (2014) Utility of thromboelastography and\/or thromboelastometry in adults with sepsis: a systematic review. Crit Care 18:R30. https:\/\/doi.org\/10.1186\/cc13721","journal-title":"Crit Care"},{"key":"7586_CR64","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181\u20131247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"7586_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13054-019-2534-2","volume":"23","author":"JA Hippensteel","year":"2019","unstructured":"Hippensteel JA, Uchimido R, Tyler PD, Burke RC, Han X, Zhang F et al (2019) Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Crit Care 23:259. https:\/\/doi.org\/10.1186\/s13054-019-2534-2","journal-title":"Crit Care"},{"key":"7586_CR66","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1097\/CCM.0000000000001853","volume":"44","author":"J Fisher","year":"2016","unstructured":"Fisher J, Douglas JJ, Linder A, Boyd JH, Walley KR, Russell JA (2016) Elevated Plasma Angiopoietin-2 Levels Are Associated With Fluid Overload, Organ Dysfunction, and Mortality in Human Septic Shock. Crit Care Med 44:2018\u20132027. https:\/\/doi.org\/10.1097\/CCM.0000000000001853","journal-title":"Crit Care Med"},{"key":"7586_CR67","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.chest.2023.04.036","volume":"164","author":"P Sivapalan","year":"2023","unstructured":"Sivapalan P, Ellekjaer KL, Jessen MK, Meyhoff TS, Cronhjort M, Hjortrup PB et al (2023) Lower vs Higher Fluid Volumes in Adult Patients With Sepsis: An Updated Systematic Review With Meta-Analysis and Trial Sequential Analysis. Chest 164:892\u2013912. https:\/\/doi.org\/10.1016\/j.chest.2023.04.036","journal-title":"Chest"},{"key":"7586_CR68","doi-asserted-by":"publisher","unstructured":"Lewis SR, Pritchard MW, Evans DJ, Butler AR, Alderson P, Smith AF, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev 2018;8:CD000567. https:\/\/doi.org\/10.1002\/14651858.CD000567.pub7.","DOI":"10.1002\/14651858.CD000567.pub7"},{"key":"7586_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004498","volume":"95","author":"KC Rasmussen","year":"2016","unstructured":"Rasmussen KC, Secher NH, Pedersen T (2016) Effect of perioperative crystalloid or colloid fluid therapy on hemorrhage, coagulation competence, and outcome: A systematic review and stratified meta-analysis. Medicine (Baltimore) 95:e4498. https:\/\/doi.org\/10.1097\/MD.0000000000004498","journal-title":"Medicine (Baltimore)"},{"key":"7586_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bpa.2008.11.002","volume":"23","author":"SA Kozek-Langenecker","year":"2009","unstructured":"Kozek-Langenecker SA (2009) Influence of fluid therapy on the haemostatic system of intensive care patients. Best Pract Res Clin Anaesthesiol 23:225\u2013236. https:\/\/doi.org\/10.1016\/j.bpa.2008.11.002","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"7586_CR71","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1378\/chest.130.4.962","volume":"130","author":"JA Kellum","year":"2006","unstructured":"Kellum JA, Song M, Almasri E (2006) Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest 130:962\u2013967. https:\/\/doi.org\/10.1378\/chest.130.4.962","journal-title":"Chest"},{"key":"7586_CR72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/PCC.0000000000003123","volume":"24","author":"J Fern\u00e1ndez-Sarmiento","year":"2023","unstructured":"Fern\u00e1ndez-Sarmiento J, Salazar-Pel\u00e1ez LM, Acevedo L, Ni\u00f1o-Serna LF, Fl\u00f3rez S, Alarc\u00f3n-Forero L et al (2023) Endothelial and Glycocalyx Biomarkers in Children With Sepsis After One Bolus of Unbalanced or Balanced Crystalloids. Pediatr Crit Care Med 24:213\u2013221. https:\/\/doi.org\/10.1097\/PCC.0000000000003123","journal-title":"Pediatr Crit Care Med"},{"key":"7586_CR73","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40635-023-00582-8","volume":"11","author":"B Saravi","year":"2023","unstructured":"Saravi B, Goebel U, Hassenzahl LO, Jung C, David S, Feldheiser A et al (2023) Capillary leak and endothelial permeability in critically ill patients: a current overview. Intensive Care Med Exp 11:96. https:\/\/doi.org\/10.1186\/s40635-023-00582-8","journal-title":"Intensive Care Med Exp"},{"key":"7586_CR74","doi-asserted-by":"publisher","unstructured":"Sandoo A, van Zanten JJCSV, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010;4:302\u201312. https:\/\/doi.org\/10.2174\/1874192401004010302.","DOI":"10.2174\/1874192401004010302"},{"key":"7586_CR75","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40635-019-0274-x","volume":"7","author":"S Lambden","year":"2019","unstructured":"Lambden S (2019) Bench to bedside review: therapeutic modulation of nitric oxide in sepsis-an update. Intensive Care Med Exp 7:64. https:\/\/doi.org\/10.1186\/s40635-019-0274-x","journal-title":"Intensive Care Med Exp"},{"key":"7586_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s44158-024-00150-w","volume":"4","author":"I Coloretti","year":"2024","unstructured":"Coloretti I, Genovese A, Teixeira JP, Cherian A, Ferrer R, Landoni G et al (2024) Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review. J Anesth Analg Crit Care 4:13. https:\/\/doi.org\/10.1186\/s44158-024-00150-w","journal-title":"J Anesth Analg Crit Care"},{"key":"7586_CR77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211370119","volume":"119","author":"DE Leisman","year":"2022","unstructured":"Leisman DE, Privratsky JR, Lehman JR, Abraham MN, Yaipan OY, Brewer MR et al (2022) Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model. Proc Natl Acad Sci U S A 119:e2211370119. https:\/\/doi.org\/10.1073\/pnas.2211370119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7586_CR78","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","volume":"194","author":"RF Stolk","year":"2016","unstructured":"Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M (2016) Potentially Inadvertent Immunomodulation: Norepinephrine Use in Sepsis. Am J Respir Crit Care Med 194:550\u2013558. https:\/\/doi.org\/10.1164\/rccm.201604-0862CP","journal-title":"Am J Respir Crit Care Med"},{"key":"7586_CR79","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","volume":"9","author":"N Heming","year":"2018","unstructured":"Heming N, Sivanandamoorthy S, Meng P, Bounab R, Annane D (2018) Immune Effects of Corticosteroids in Sepsis. Front Immunol 9:1736. https:\/\/doi.org\/10.3389\/fimmu.2018.01736","journal-title":"Front Immunol"},{"key":"7586_CR80","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.chest.2017.07.014","volume":"152","author":"N Barabutis","year":"2017","unstructured":"Barabutis N, Khangoora V, Marik PE, Catravas JD (2017) Hydrocortisone and Ascorbic Acid Synergistically Prevent and Repair Lipopolysaccharide-Induced Pulmonary Endothelial Barrier Dysfunction. Chest 152:954\u2013962. https:\/\/doi.org\/10.1016\/j.chest.2017.07.014","journal-title":"Chest"},{"key":"7586_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00024382-200301000-00008","volume":"19","author":"A Mansart","year":"2003","unstructured":"Mansart A, Bollaert PE, Seguin C, Levy B, Longrois D, Malli\u00e9 JP (2003) Hemodynamic effects of early versus late glucocorticosteroid administration in experimental septic shock. Shock 19:38\u201344. https:\/\/doi.org\/10.1097\/00024382-200301000-00008","journal-title":"Shock"},{"key":"7586_CR82","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2567.2007.02611.x","volume":"122","author":"H-Y Lim","year":"2007","unstructured":"Lim H-Y, M\u00fcller N, Herold MJ, van den Brandt J, Reichardt HM (2007) Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 122:47\u201353. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02611.x","journal-title":"Immunology"},{"key":"7586_CR83","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R et al (2018) Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med 378:797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835","journal-title":"N Engl J Med"},{"key":"7586_CR84","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S et al (2018) Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med 378:809\u2013818. https:\/\/doi.org\/10.1056\/NEJMoa1705716","journal-title":"N Engl J Med"},{"key":"7586_CR85","doi-asserted-by":"publisher","unstructured":"Pirracchio R, Annane D, Waschka AK, Lamontagne F, Arabi YM, Bollaert P-E, et al. Patient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock. NEJM Evid 2023;2:EVIDoa2300034. https:\/\/doi.org\/10.1056\/EVIDoa2300034.","DOI":"10.1056\/EVIDoa2300034"},{"key":"7586_CR86","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.2015.88","volume":"313","author":"A Torres","year":"2015","unstructured":"Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677\u2013686. https:\/\/doi.org\/10.1001\/jama.2015.88","journal-title":"JAMA"},{"key":"7586_CR87","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"P-F Dequin","year":"2023","unstructured":"Dequin P-F, Meziani F, Quenot J-P, Kamel T, Ricard J-D, Badie J et al (2023) Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med 388:1931\u20131941. https:\/\/doi.org\/10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"7586_CR88","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.chest.2022.08.2229","volume":"163","author":"N Saleem","year":"2023","unstructured":"Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N (2023) Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials. Chest 163:484\u2013497. https:\/\/doi.org\/10.1016\/j.chest.2022.08.2229","journal-title":"Chest"},{"key":"7586_CR89","doi-asserted-by":"publisher","unstructured":"Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2019;2:CD010406. https:\/\/doi.org\/10.1002\/14651858.CD010406.pub3.","DOI":"10.1002\/14651858.CD010406.pub3"},{"key":"7586_CR90","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R et al (2024) 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med 52:e219\u2013e233. https:\/\/doi.org\/10.1097\/CCM.0000000000006172","journal-title":"Crit Care Med"},{"key":"7586_CR91","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice TW, Wheeler AP, Bernard GR, Vincent J-L, Angus DC, Aikawa N et al (2010) A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 38:1685\u20131694. https:\/\/doi.org\/10.1097\/CCM.0b013e3181e7c5c9","journal-title":"Crit Care Med"},{"key":"7586_CR92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA et al (2016) Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med 44:275\u2013281. https:\/\/doi.org\/10.1097\/CCM.0000000000001402","journal-title":"Crit Care Med"},{"key":"7586_CR93","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-2600(23)00158-3","volume":"11","author":"B Fran\u00e7ois","year":"2023","unstructured":"Fran\u00e7ois B, Lambden S, Fivez T, Gibot S, Derive M, Grouin J-M et al (2023) Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial. Lancet Respir Med 11:894\u2013904. https:\/\/doi.org\/10.1016\/S2213-2600(23)00158-3","journal-title":"Lancet Respir Med"},{"key":"7586_CR94","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","volume":"9","author":"J Cui","year":"2019","unstructured":"Cui J, Wei X, Lv H, Li Y, Li P, Chen Z et al (2019) The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis. Ann Intensive Care 9:27. https:\/\/doi.org\/10.1186\/s13613-019-0501-3","journal-title":"Ann Intensive Care"},{"key":"7586_CR95","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","volume":"47","author":"P-F Laterre","year":"2021","unstructured":"Laterre P-F, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T et al (2021) Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intensive Care Med 47:1284\u20131294. https:\/\/doi.org\/10.1007\/s00134-021-06537-5","journal-title":"Intensive Care Med"},{"key":"7586_CR96","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.201301-0136LE","volume":"188","author":"J Aman","year":"2013","unstructured":"Aman J, Peters MJL, Weenink C, van Nieuw Amerongen GP, Vonk NA (2013) Reversal of vascular leak with imatinib. Am J Respir Crit Care Med 188:1171\u20131173. https:\/\/doi.org\/10.1164\/rccm.201301-0136LE","journal-title":"Am J Respir Crit Care Med"},{"key":"7586_CR97","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/CCM.0b013e31819c06bc","volume":"37","author":"F Jaimes","year":"2009","unstructured":"Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D et al (2009) Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med 37:1185\u20131196. https:\/\/doi.org\/10.1097\/CCM.0b013e31819c06bc","journal-title":"Crit Care Med"},{"key":"7586_CR98","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jth.12643","volume":"12","author":"T Tagami","year":"2014","unstructured":"Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H (2014) Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost 12:1470\u20131479. https:\/\/doi.org\/10.1111\/jth.12643","journal-title":"J Thromb Haemost"},{"key":"7586_CR99","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","volume":"366","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Thompson BT, Barie PS, Dhainaut J-F, Douglas IS, Finfer S et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055\u20132064. https:\/\/doi.org\/10.1056\/NEJMoa1202290","journal-title":"N Engl J Med"},{"key":"7586_CR100","doi-asserted-by":"publisher","unstructured":"Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001;286:1869\u201378. https:\/\/doi.org\/10.1001\/jama.286.15.1869.","DOI":"10.1001\/jama.286.15.1869"},{"key":"7586_CR101","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jama.290.2.238","volume":"290","author":"E Abraham","year":"2003","unstructured":"Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL et al (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290:238\u2013247. https:\/\/doi.org\/10.1001\/jama.290.2.238","journal-title":"JAMA"},{"key":"7586_CR102","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"J-L Vincent","year":"2019","unstructured":"Vincent J-L, Francois B, Zabolotskikh I, Daga MK, Lascarrou J-B, Kirov MY et al (2019) Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. JAMA 321:1993\u20132002. https:\/\/doi.org\/10.1001\/jama.2019.5358","journal-title":"JAMA"},{"key":"7586_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13613-021-00842-4","volume":"11","author":"B Fran\u00e7ois","year":"2021","unstructured":"Fran\u00e7ois B, Fiancette M, Helms J, Mercier E, Lascarrou J-B, Kayanoki T et al (2021) Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET. Ann Intensive Care 11:53. https:\/\/doi.org\/10.1186\/s13613-021-00842-4","journal-title":"Ann Intensive Care"},{"key":"7586_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","volume":"5","author":"H Saito","year":"2007","unstructured":"Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R et al (2007) Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost 5:31\u201341. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02267.x","journal-title":"J Thromb Haemost"},{"key":"7586_CR105","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1182\/blood-2010-02-269746","volume":"116","author":"R Silasi-Mansat","year":"2010","unstructured":"Silasi-Mansat R, Zhu H, Popescu NI, Peer G, Sfyroera G, Magotti P et al (2010) Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 116:1002\u20131010. https:\/\/doi.org\/10.1182\/blood-2010-02-269746","journal-title":"Blood"},{"key":"7586_CR106","doi-asserted-by":"publisher","first-page":"E6390","DOI":"10.1073\/pnas.1706818114","volume":"114","author":"RS Keshari","year":"2017","unstructured":"Keshari RS, Silasi R, Popescu NI, Patel MM, Chaaban H, Lupu C et al (2017) Inhibition of complement C5 protects against organ failure and reduces mortality in a baboon model of Escherichia coli sepsis. Proc Natl Acad Sci U S A 114:E6390\u2013E6399. https:\/\/doi.org\/10.1073\/pnas.1706818114","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07586-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07586-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07586-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T06:03:18Z","timestamp":1727848998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07586-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["7586"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07586-2","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MG has received honoraria for speaking at conferences and advisory services from Viatris and, Biotest related to the topic of this study; SD received support for travel, research and speaker honoraria from Cytosorbents, Terumo and Octapharma, OrphaSwiss, Bayer, Orion and Alexion; RF has received honoraria for speaking at conferences and advisory services from Viatris, Grifols and AOP related to the topic of this study; JH has received honoraria for lectures from Diagnostica Stago, Pfizer PFE France and Sanofi Aventis France; NJ receives an unrestricted grant from Octapharma for investigator initiated research on shock-induced endotheliopathy; IM-L honoraria for speaking at conferences and advisory services from Gilead, Thermofisher, MSD, Mundipharma Pfizer, Mundipharma, MSD and Biocodex; TI advisory boards of Japan Blood Products Organization, Asahi Kasei Pharmaceuticals, and Toray Medical; research grant from JIMRO; NDN received honoraria for advisory board services for Adrenomed and Inotrem.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}